Sarah Hamidi

Sep 9, 2024 | digitalcommons.library.tmc.edu | Sarah Hamidi |Marie-Claude Hofmann |Priyanka Iyer |Maria E Cabanillas

The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs) has undergone major advancements in the last decade, causing a paradigm shift in the management and prognosis of these patients.

Jul 11, 2024 | jamanetwork.com | Sarah Hamidi |Hormonal Disorders |Mark E. Zafereo |Jennifer Wang

Abstract Importance  BRAF/MEK inhibitors revolutionized the treatment of BRAF V600E-variant anaplastic thyroid carcinoma (BRAFv-ATC), offering improved outcomes for patients with this previously incurable disease. Observations  Anaplastic thyroid carcinoma (ATC) accounts for approximately half of thyroid cancer−related deaths.

Jul 6, 2023 | pubmed.ncbi.nlm.nih.gov | Sarah Hamidi |Anastasios Maniakas

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software